Recently, Guangzhou Biolight Biotechnology Co., Ltd (hereinafter referred to as BLT) announced that its Aniview100 Pro Multi-modal Animal Imaging System (hereinafter referred to as AniView100 Pro) has passed the strict technical evaluation of the Polish Academy of Sciences (Instytut Biologii Doświadczalnej imienia) and has successfully won the bidding of the procurement project of animal live imaging equipment of the Academy. This is also a major breakthrough in the internationalization strategy of BLT's in vivo imaging systems, following the AniView Phoenix full-spectrum animal in vivo imaging system at Karolinska Medical School in Sweden and the Aniview Kirin small animal in vivo 3D imaging system at Ankara Medical School in Turkey.
Technical strength wins international trust
The AniView100 Pro, with its high optical imaging sensitivity and multimodal imaging ability, is particularly suitable for cutting-edge life science research in the areas of tumor, inflammation, metabolism, pharmacokinetics, etc. The Polish Academy of Sciences, as one of the leading research institutions in Europe, has made great demands in terms of technical specifications and service support.The AniView100 Pro was selected among many other international brands due to its excellent performance and localized service capabilities.
Quality service helps research and innovation
A team of professional engineers from BLT went to the site of Polish Academy of Sciences to install the equipment, and provided the researchers with system operation and application training, covering the core contents of multimodal imaging, ROI analysis, fluorescence/bioluminescence imaging process, etc., which helped the customer to carry out high-level molecular imaging research on small animals quickly.
China's Smart Manufacturing rewrites the industry's competitive landscape
The Polish Academy of Sciences is one of the most influential scientific research institutions in Europe. Their choice of BLT is not only a recognition of the product's technical strength, but also a high degree of trust in China's smart manufacturing. This is not only a breakthrough for a single product, but also a sign that China's high-end scientific research instruments are moving from “technology following” to “innovation leading”. Dr. Luo Wenbo, Founder and CEO of BLT, emphasized: “The choice of the Polish Academy of Sciences is the best affirmation of our ‘Core science and technology’ strategy. The company invests more than 15% of its annual revenue in R&D, and has accumulated a number of core patents in the field of in vivo imaging, forming an all-technology matrix from 2D to 3D, from visible to NIR-II, from optical to CT, and from animal to plant.”
In the future, BLT plans to set up several technical service centers around the world to synchronize the promotion and application of BLT's series of products and to provide comprehensive services and solutions for researchers around the world!